Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Lyerly

Showing results (31-40 of 218) with videos related to

Pageof 22
Sort By:
International Reviews of Immunology|May 15, 2003
Current status of dendritic cell immunotherapy of malignanciesPaul J Mosca, Timothy M Clay, H Kim Lyerly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pyloriStephen Y Chui, Timothy M Clay, H Kim Lyerly, et al.
Expert Opinion on Biological Therapy|August 21, 2007
CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapyYanal M Murad, Timothy M Clay, H Kim Lyerly, et al.
Journal of Environmental and Public Health|October 16, 2020
Uterine Cancer Mortality in White and African American Females in Southeastern North CarolinaJulia Kravchenko, Igor Akushevich, Sung Han Rhew, et al.
Cancer Treatment and Research|October 11, 2005
Immune monitoringPaul J Mosca, Timothy M Clay, Michael A Morse, et al.
Expert Opinion on Biological Therapy|January 5, 2002
Dendritic cell maturation in active immunotherapy strategiesMichael A Morse, Paul J Mosca, Timothy M Clay, et al.
North Carolina Medical Journal|September 20, 2018
Mortality and Health Outcomes in North Carolina Communities Located in Close Proximity to Hog Concentrated Animal Feeding OperationsJulia Kravchenko, Sung Han Rhew, Igor Akushevich, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2005
NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activityTakuya Osada, Timothy Clay, Amy Hobeika, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Biomarkers and correlative endpoints for immunotherapy trialsMichael A Morse, Takuya Osada, Amy Hobeika, et al.
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in colon cancerMichael Morse, Lee Langer, Alexander Starodub, et al.
Pageof 22

Showing results (31-40 of 218) with videos related to

Sort By:
Pageof 22
International Reviews of Immunology|May 15, 2003
Current status of dendritic cell immunotherapy of malignanciesPaul J Mosca, Timothy M Clay, H Kim Lyerly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pyloriStephen Y Chui, Timothy M Clay, H Kim Lyerly, et al.
Expert Opinion on Biological Therapy|August 21, 2007
CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapyYanal M Murad, Timothy M Clay, H Kim Lyerly, et al.
Journal of Environmental and Public Health|October 16, 2020
Uterine Cancer Mortality in White and African American Females in Southeastern North CarolinaJulia Kravchenko, Igor Akushevich, Sung Han Rhew, et al.
Cancer Treatment and Research|October 11, 2005
Immune monitoringPaul J Mosca, Timothy M Clay, Michael A Morse, et al.
Expert Opinion on Biological Therapy|January 5, 2002
Dendritic cell maturation in active immunotherapy strategiesMichael A Morse, Paul J Mosca, Timothy M Clay, et al.
North Carolina Medical Journal|September 20, 2018
Mortality and Health Outcomes in North Carolina Communities Located in Close Proximity to Hog Concentrated Animal Feeding OperationsJulia Kravchenko, Sung Han Rhew, Igor Akushevich, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2005
NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activityTakuya Osada, Timothy Clay, Amy Hobeika, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Biomarkers and correlative endpoints for immunotherapy trialsMichael A Morse, Takuya Osada, Amy Hobeika, et al.
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in colon cancerMichael Morse, Lee Langer, Alexander Starodub, et al.
Pageof 22